177 related articles for article (PubMed ID: 21751234)
21. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells.
Balasubramaniyan V; Boddeke E; Bakels R; Küst B; Kooistra S; Veneman A; Copray S
Neuroscience; 2006 Dec; 143(4):939-51. PubMed ID: 17084985
[TBL] [Abstract][Full Text] [Related]
22. Histone deacetylase activity is required for human oligodendrocyte progenitor differentiation.
Conway GD; O'Bara MA; Vedia BH; Pol SU; Sim FJ
Glia; 2012 Dec; 60(12):1944-53. PubMed ID: 22927334
[TBL] [Abstract][Full Text] [Related]
23. HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability.
Krishnan M; Singh AB; Smith JJ; Sharma A; Chen X; Eschrich S; Yeatman TJ; Beauchamp RD; Dhawan P
Oncogene; 2010 Jan; 29(2):305-12. PubMed ID: 19881542
[TBL] [Abstract][Full Text] [Related]
24. Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism.
Hui KF; Chiang AK
Int J Cancer; 2014 Dec; 135(12):2950-61. PubMed ID: 24771510
[TBL] [Abstract][Full Text] [Related]
25. Regulated expression and role of c-Myb in the cardiovascular-directed differentiation of mouse embryonic stem cells.
Ishida M; El-Mounayri O; Kattman S; Zandstra P; Sakamoto H; Ogawa M; Keller G; Husain M
Circ Res; 2012 Jan; 110(2):253-64. PubMed ID: 22116818
[TBL] [Abstract][Full Text] [Related]
26. The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21.
Son DS; Wilson AJ; Parl AK; Khabele D
Cancer Biol Ther; 2010 Jun; 9(11):928-35. PubMed ID: 20404564
[TBL] [Abstract][Full Text] [Related]
27. Trichostatin A, a histone deacetylase inhibitor suppresses NADPH Oxidase 4-Derived Redox Signalling and Angiogenesis.
Hakami NY; Dusting GJ; Peshavariya HM
J Cell Mol Med; 2016 Oct; 20(10):1932-44. PubMed ID: 27297729
[TBL] [Abstract][Full Text] [Related]
28. Lacking cytokine production in ES cells and ES-cell-derived vascular cells stimulated by TNF-alpha is rescued by HDAC inhibitor trichostatin A.
Zampetaki A; Zeng L; Xiao Q; Margariti A; Hu Y; Xu Q
Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1226-38. PubMed ID: 17626239
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice.
Chen Y; Du J; Zhao YT; Zhang L; Lv G; Zhuang S; Qin G; Zhao TC
Cardiovasc Diabetol; 2015 Aug; 14():99. PubMed ID: 26245924
[TBL] [Abstract][Full Text] [Related]
30. Changes in cardiac Nav1.5 expression, function, and acetylation by pan-histone deacetylase inhibitors.
Xu Q; Patel D; Zhang X; Veenstra RD
Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1139-H1149. PubMed ID: 27638876
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Histone Deacetylases Enhances the Osteogenic Differentiation of Human Periodontal Ligament Cells.
Huynh NC; Everts V; Pavasant P; Ampornaramveth RS
J Cell Biochem; 2016 Jun; 117(6):1384-95. PubMed ID: 27043246
[TBL] [Abstract][Full Text] [Related]
32. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.
Suenaga M; Soda H; Oka M; Yamaguchi A; Nakatomi K; Shiozawa K; Kawabata S; Kasai T; Yamada Y; Kamihira S; Tei C; Kohno S
Int J Cancer; 2002 Feb; 97(5):621-5. PubMed ID: 11807787
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat.
Choi SY; Kee HJ; Jin L; Ryu Y; Sun S; Kim GR; Jeong MH
Biomed Pharmacother; 2018 May; 101():145-154. PubMed ID: 29482060
[TBL] [Abstract][Full Text] [Related]
34. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
35. Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation.
Hyndman KA; Kasztan M; Mendoza LD; Monteiro-Pai S
Am J Physiol Renal Physiol; 2019 May; 316(5):F875-F888. PubMed ID: 30810062
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury.
Zhao TC; Cheng G; Zhang LX; Tseng YT; Padbury JF
Cardiovasc Res; 2007 Dec; 76(3):473-81. PubMed ID: 17884027
[TBL] [Abstract][Full Text] [Related]
37. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
Shi QQ; Zuo GW; Feng ZQ; Zhao LC; Luo L; You ZM; Li DY; Xia J; Li J; Chen DL
Asian Pac J Cancer Prev; 2014; 15(18):7849-55. PubMed ID: 25292076
[TBL] [Abstract][Full Text] [Related]
38. Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases.
Thakur VS; Gupta K; Gupta S
Carcinogenesis; 2012 Feb; 33(2):377-84. PubMed ID: 22114073
[TBL] [Abstract][Full Text] [Related]
39. MiR-199a-3p inhibition facilitates cardiomyocyte differentiation of embryonic stem cell through promotion of MEF2C.
Chen HP; Wen J; Tan SR; Kang LM; Zhu GC
J Cell Physiol; 2019 Dec; 234(12):23315-23325. PubMed ID: 31140610
[TBL] [Abstract][Full Text] [Related]
40. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
Choi YH
Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
